Log in

Relevant bibliographies by topics / Lymphocyte therapy / Books

To see the other types of publications on this topic, follow the link: Lymphocyte therapy.

Books on the topic 'Lymphocyte therapy'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Lymphocyte therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Raut, Mohan, and Mugdha Raut. Lymphocyte Immunization Therapy (LIT) in Reproductive Failures. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2960-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Alexander, Michael A. Immune-based cancer treatment: The T lymphocyte response. CRC Press, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Jean-Marie, Andrieu, Lu Wei, and International Symposium on Cellular Approaches to the Control of HIV Disease (1st : 1994 : Paris, France), eds. Cell activation and apoptosis in HIV infection: Implications for pathogenesis and therapy. Plenum Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Alexander, Michael A. Immune-based cancer treatment: The T lymphocyte response. CRC Press, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

1933-, Koldovksy P., ed. Lymphocytes in immunotherapy of cancer. Springer-Verlag, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hancock, Sarah. Fludarabine as first line therapy for chronic lymphocytic leukaemia. University of Birmingham, Department of Public Health and Epidemiology, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Chadi, Nabhan, ed. Chronic lymphocytic leukemia research focus. Nova Science Publishers, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

1956-, Zhang Jingwu, and Cohen Irun R, eds. T-cell vaccination. Nova Biomedical Books, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

I, Gabrilovich Dmitry, and Hurwitz Arthur A, eds. Tumor-induced immune suppression: Mechanisms and therapeutic reversal. Springer, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

C, Hyde, National Co-ordinating Centre for HTA (Great Britain), and Health Technology Assessment Programme, eds. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: A technology assessment. Core Research on behalf of the NCCHTA, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Giorgio, Parmiani, and Lotze Michael T, eds. Tumor immunology: Molecularly defined antigens and clinical applications. Taylor & Francis, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Bahiru, Gametchu, ed. Glucocorticoid receptor structure and leukemic cell responses. Springer-Verlag, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Burkhard, Ludewig, and Hoffmann Matthias W, eds. Adoptive immunotherapy: Methods and protocols. Humana Press, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

1944-, Finke James H., and Bukowski Ronald M, eds. Cancer immunotherapy at the crossroads: How tumors evade immunity and what can be done. Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

1944-, Finke James H., and Bukowski Ronald M, eds. Cancer immunotherapy at the crossroads: How tumors evade immunity and what can be done. Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

J, McMichael Andrew, Bodmer W. F. 1936-, and Imperial Cancer Research Fund (Great Britain), eds. A New look at tumour immunology. Cold Spring Harbor Laboratory Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Gupta, Sudhir. Mechanisms of Lymphocyte Activation and Immune Regulation VIII: Autoimmunity 2000 and Beyond. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Gupta, Sudhir. Mechanisms of Lymphocyte Activation and Immune Regulation VIII: Autoimmunity 2000 and Beyond. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Raut, Mohan, and Mugdha Raut. Lymphocyte Immunization Therapy in Reproductive Failures: New Horizons. Springer, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lymphocyte Immunization Therapy in Reproductive Failures: New Horizons. Springer, 2023.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Jolles, G., ed. T-lymphocyte And Inflammatory Cell Research In Asthma. Academic Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Taylor, Jack H., G. Jolles, and J. A. Karlsson. T-Lymphocyte and Inflammatory Cell Research in Asthma. Elsevier Science & Technology Books, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

T-Lymphocyte and Inflammatory Cell Research in Asthma. Academic Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Andrieu, Jean-Marie, and Wei Lu. Cell Activation and Apoptosis in HIV Infection: Implications for Pathogenesis and Therapy. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Immunotherapy of cancer with sensitized T lymphocytes. R.G. Landes, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hjalgrim, Henrik, Ellen T. Chang, and Sally L. Glaser. Hodgkin Lymphoma. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0039.

Full text

Abstract:

Hodgkin lymphoma (HL) is a malignant neoplasm of the lymphatic system. The malignant cell clone derives from germinal center B lymphocytes in ~98% of cases, the rest being of T-lymphocyte origin. Each year, HL is diagnosed in roughly 66,000 individuals worldwide. HL is curable with modern therapy in the vast majority of patients, with five-year survival rates exceeding 90% for early-stage disease. However, so far this excellent prognosis has been achieved at the expense of a high incidence of severe long-term treatment complications such as secondary malignancies, and endocrine and cardiovascu

APA, Harvard, Vancouver, ISO, and other styles

27

Davidson, Ben, Pinar Firat, and Claire W. Michael. Serous Effusions: Etiology, Diagnosis, Prognosis and Therapy. Springer, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Davidson, Ben, Claire W. Michael, and Pİnar Fİrat. Serous Effusions: Etiology, Diagnosis, Prognosis and Therapy. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Fİrat, Pİnar, Ben Davidson, and Claire W. Michael. Serous Effusions: Etiology, Diagnosis, Prognosis and Therapy. Springer London, Limited, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Davidson, Ben, Pinar Firat, and Claire W. Michael. Serous Effusions: Etiology, Diagnosis, Prognosis and Therapy. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Hull, Mark, and Steven C. Reynolds. HIV in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0291.

Full text

Abstract:

It has been over 30 years since the recognition of the acquired immune deficiency syndrome (AIDS), linked to infection with human immunodeficiency virus (HIV). Opportunistic infections arise in the setting of decreases in the CD4+ T-lymphocyte count. Advances in the safety, and effectiveness of combination antiretroviral therapy (cART) have led to substantial improvements in life-expectancy for individuals accessing successful therapy. As such individuals are likely to be admitted to the intensive care unit (ICU) for conditions un-related to HIV, although presentations due to opportunistic inf

APA, Harvard, Vancouver, ISO, and other styles

32

(Editor), Susan O'Brien, and John G. Gribben (Editor), eds. Chronic Lymphocytic Leukemia. Informa Healthcare, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Henggeller, Michelle. Infections in the HIV Patient. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0055.

Full text

Abstract:

The hallmark of the human immunodeficiency virus (HIV) patient with a cluster of differentiation 4 (CD4) T lymphocyte count below 200 is the development of opportunistic infections. Although the use of antiretroviral therapy (ART) has decreased the incidence of these infections, they continue to be a major case of morbidity and mortality in the patient with HIV. These infections can be respiratory in nature and present with cough or shortness of breath: Pneumocystis pneumonia (PCP), tuberculosis (TB), aspergillosis, and coccidioidomycosis. Neurological infections, which can present with change

APA, Harvard, Vancouver, ISO, and other styles

34

Misbah, Siraj. Immunosuppressive therapy and therapeutic monoclonal antibodies. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0302.

Full text

Abstract:

The term immunosuppressive therapy encompasses all forms of treatment that dampens function of the recipient’s immune system, with a view to controlling severe autoimmune, inflammatory, or allergic disease. The predominant targets of these agents are T-lymphocytes with multiple downstream effects, including containment of T-cell activation, inhibition of cytokine production, restriction of clonal expansion, and varying degrees of suppression of B-cell function. This chapter reviews the clinical use of monoclonal antibodies and other immunosuppressive agents, and their mechanisms of action.

APA, Harvard, Vancouver, ISO, and other styles

35

(Editor), Doriano Fabbro, and Frank McCormick (Editor), eds. Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development). Humana Press, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

McCormick, Frank. Protein Tyrosine Kinases: From Inhibitors to Useful Drugs. Humana Press, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

McCormick, Frank, and Doriano Fabbro. Protein Tyrosine Kinases: From Inhibitors to Useful Drugs. Humana Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Campath - 1 H: Emerging Frontline Therapy in Chronic Lymphocytic Leukemia. Informa Healthcare, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Nabhan, Chadi. Chronic Lymphocytic Leukemia Research Focus. Nova Science Pub Inc, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Hawkins, Robert E. Cellular Therapy of Cancer: Development of Gene Therapy Based Approaches. World Scientific Publishing Co Pte Ltd, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Cellular Therapy Of Cancer. World Scientific Publishing Company, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

OLDSTONE. Cytotoxic T-Lymphocytes in Human Viral & Malaria Infections. Springer, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Vigil, Karen J. Non-opportunistic Infections. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0036.

Full text

Abstract:

Lymphocytic interstitial pneumonitis is a common respiratory complication of HIV infection in children but a rare complication in HIV-infected adults. The diagnosis requires histologic confirmation by biopsy. Antiretroviral therapy has been used with success for treatment. Nonspecific interstitial pneumonitis (NSIP) presents with dyspnea, nonproductive cough, and fever in patients with CD4+ T cell counts >200 cells/mm3. The diagnosis of NSIP requires histologic confirmation by biopsy. The optimum treatment remains unclear. The prevalence of pulmonary arterial hypertension (PAH) is higher in

APA, Harvard, Vancouver, ISO, and other styles

44

Gabrilovich, Dmitry I., and Arthur Andrew Hurwitz. Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gabrilovich, Dmitry I., and Arthur Andrew Hurwitz. Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Gabrilovich, Dmitry I., and Arthur Andrew Hurwitz. Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. Springer London, Limited, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Gabrilovich, Dmitry I., and Arthur Andrew Hurwitz. Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Bauer, Jan, and Christian G. Bien. Rasmussen Encephalitis. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0096.

Full text

Abstract:

Rasmussen encephalitis (RE) is a rare epileptic disorder that is characterized by the presence of unihemispheric seizures coinciding with inflammation. The disease mostly presents in children. Clinically, patients often reach a residual stage with drug resistant seizures and severe neurological deficits. Pathologically, at this stage, the brain shows variable neuronal loss. The etiology is unknown but the infiltration of large numbers of CD8 positive T lymphocytes suggests that this is an autoimmune disease. Treatment consists of anti-inflammatory therapy (IVIG or tacrolimus), which, however,

APA, Harvard, Vancouver, ISO, and other styles

49

Hasbun, Rodrigo, Richard Dunham, Joseph S. Kass, et al. HIV-Associated Neurocognitive Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0038.

Full text

Abstract:

HIV causes a chronic form of encephalitis (HIVE) that is clinically characterized by either dementia or mild neurocognitive impairment. Since the introduction of antiretroviral therapy in 1996, the incidence of HIV dementia has decreased by 50%, but the prevalence of mild neurocognitive disorder has increased up to 39%. HIVE is the result of direct microglial infection, interruption of trophic factors, or caused by inflammatory cytokines. HIV enters the brain primarily by the “Trojan horse mechanism”; it is carried by monocytes and lymphocytes that cross the blood–brain barrier. HIV has a pred

APA, Harvard, Vancouver, ISO, and other styles

50

Farghaly, Samir A. Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0005.

Full text

Abstract:

The standard management for epithelial ovarian cancer (EOC) is a combination of aggressive debulking surgery with residual tumor of less than 1 cm and platinum-based chemotherapy. However, a high percentage of patients experience disease recurrence. Extensive efforts to find new therapeutic options have been made, albeit cancer cells develop drug resistance and malignant progression occurs. Novel therapeutic strategies are needed to enhance progression-free survival and overall survival of patients with advanced EOC. Several preclinical and clinical studies investigated feasibility and efficac

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!